Anthem Biosciences IPO: Check out 10 key things to know from RHP before investing

Anthem Biosciences has launched its IPO on July 14, closing on July 16. The ₹3,395 crore offer is entirely for sale by existing shareholders, with proceeds going to them. Allocation includes 50% for QIBs, 15% for NIIs, and 35% for retail investors.

Markets